Cyclopharm Limited (ASX:CYC)
0.4500
+0.0250 (5.88%)
Nov 2, 2026, 2:07 PM AEDT
Cyclopharm Market Cap
Cyclopharm has a market cap or net worth of 56.58 million as of October 30, 2026. It is the 32,133rd most valuable company in the world and the 746th biggest in Australia. Its market cap has decreased by 19.83% in one year.
Market Cap
56.58M
Enterprise Value
52.14M
Revenue
34.42M
Global Rank
Country Rank
#746 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2007, Cyclopharm's market cap has increased from 50.89M to 56.58M, an increase of 11.18%. That is a compound annual growth rate of 0.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 56.58M | -48.05% |
| Dec 30, 2025 | 108.91M | -38.17% |
| Dec 31, 2024 | 176.15M | -2.75% |
| Dec 29, 2023 | 181.14M | 66.37% |
| Dec 30, 2022 | 108.87M | -28.90% |
| Dec 30, 2021 | 153.13M | -23.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SomnoMed | 63.73M |
| Saluda Medical | 61.75M |
| Lumos Diagnostics Holdings | 58.30M |
| Epiminder | 57.42M |
| Compumedics | 47.94M |
| HeraMED | 42.87M |
| Nova Eye Medical | 42.74M |
| Cleo Diagnostics | 40.45M |